Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-03-30
2009-02-24
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S188000, C546S187000, C546S190000
Reexamination Certificate
active
07495013
ABSTRACT:
The present invention relates to compounds of formula (I):The variables recited in formula (I) are defined in the specification. The present invention also relates to processes of preparing compounds of formula (I) and uses of such compounds for treating a chemokine (e.g., CCR3) or H1 mediated disease state.
REFERENCES:
patent: 4505915 (1985-03-01), Hannah
patent: 4588722 (1986-05-01), Janssens et al.
patent: 4695575 (1987-09-01), Janssens et al.
patent: 5883096 (1999-03-01), Lowe et al.
patent: 5889006 (1999-03-01), Lowe et al.
patent: 5952349 (1999-09-01), Asberom et al.
patent: 5977138 (1999-11-01), Wang et al.
patent: 6066636 (2000-05-01), Kozlowski et al.
patent: 6294554 (2001-09-01), Clader et al.
patent: 6387930 (2002-05-01), Baroudy et al.
patent: 6440440 (2002-08-01), Meerpoel et al.
patent: 6525070 (2003-02-01), Rigby et al.
patent: 6759411 (2004-07-01), Ko et al.
patent: 6903115 (2005-06-01), Rigby et al.
patent: 7179922 (2007-02-01), Lawrence et al.
patent: 7186718 (2007-03-01), Gustafsson et al.
patent: 7238691 (2007-07-01), Sanganee et al.
patent: 7238811 (2007-07-01), Lawrence et al.
patent: 7265227 (2007-09-01), Evans et al.
patent: 7307090 (2007-12-01), Evans et al.
patent: 2005/0176708 (2005-08-01), Luckhurst et al.
patent: 2005/0182094 (2005-08-01), Sanganee et al.
patent: 2006/0040984 (2006-02-01), Luckhurst et al.
patent: 2006/0264463 (2006-11-01), Luckhurst et al.
patent: 2006/0281726 (2006-12-01), Luckhurst et al.
patent: 2007/0179297 (2007-08-01), Lawrence et al.
patent: 0 099 139 (1984-01-01), None
patent: 0 121 972 (1984-10-01), None
patent: 0 145 037 (1985-06-01), None
patent: 0 151 824 (1985-08-01), None
patent: 0 151 826 (1985-08-01), None
patent: 1 076 055 (2001-02-01), None
patent: 1 362 857 (2003-11-01), None
patent: 1 389 616 (2004-02-01), None
patent: 1250719 (1971-10-01), None
patent: 2 373 186 (2002-09-01), None
patent: WO 93/10091 (1993-05-01), None
patent: WO 95/08535 (1995-03-01), None
patent: WO 96/26196 (1996-08-01), None
patent: WO 96/34857 (1996-11-01), None
patent: WO 96/41631 (1996-12-01), None
patent: WO 97/24324 (1997-07-01), None
patent: WO 98/01425 (1998-01-01), None
patent: WO 98/05291 (1998-02-01), None
patent: WO 98/05292 (1998-02-01), None
patent: WO 98/06697 (1998-02-01), None
patent: WO 98/11128 (1998-03-01), None
patent: WO 99/04794 (1999-02-01), None
patent: WO 99/37304 (1999-07-01), None
patent: WO 99/38514 (1999-08-01), None
patent: WO 99/51578 (1999-10-01), None
patent: WO 99/55324 (1999-11-01), None
patent: WO 00/00488 (2000-01-01), None
patent: WO 00/12478 (2000-03-01), None
patent: WO 00/32590 (2000-06-01), None
patent: WO 00/35877 (2000-06-01), None
patent: WO 00/66559 (2000-11-01), None
patent: WO 01/02381 (2001-01-01), None
patent: WO 01/07436 (2001-02-01), None
patent: WO 01/29066 (2001-04-01), None
patent: WO 01/77101 (2001-10-01), None
patent: WO 01/92227 (2001-12-01), None
patent: WO 02/18335 (2002-03-01), None
patent: WO 02/20484 (2002-03-01), None
patent: WO 02/072570 (2002-03-01), None
patent: WO 02/066460 (2002-08-01), None
patent: WO 02/079190 (2002-10-01), None
patent: WO 02/079194 (2002-10-01), None
patent: WO 02/081449 (2002-10-01), None
patent: WO 03/004487 (2003-01-01), None
patent: WO 03/018576 (2003-03-01), None
patent: WO 03/020716 (2003-03-01), None
patent: WO 03/022277 (2003-03-01), None
patent: WO 03/024962 (2003-03-01), None
patent: WO 03/078395 (2003-09-01), None
patent: WO 03/078421 (2003-09-01), None
patent: WO 2005/126947 (2003-11-01), None
patent: WO 2004/029041 (2004-04-01), None
patent: WO 2004/085423 (2004-10-01), None
patent: WO 2004/099144 (2004-11-01), None
patent: WO 2004/113323 (2004-12-01), None
patent: WO 2005/097775 (2005-10-01), None
patent: WO 2006/126948 (2006-11-01), None
patent: WO 2007/011293 (2007-01-01), None
Harada et al., “NovelN-[1-(Substituted 4-Piperidinylmethyl)-4-piperidinyl]benzamides as Potent Colonic Prokinetic Agents”,Bioorganic&Medicinal Chemistry Letters12:967-970 (2002).
Hodgson et al., “Chemokines and Drug Discovery”,Drug New Perspect17(5):335-338 (2004).
Hoffman et al., “The Preparation of 2-Hydrazinyl Esters in High Optical Purity from 2-Sulfonyloxy Esters”,Tetrahedron Letters31(21):2953-2956 (1990).
Allain et al., (2005) STN International, HCAPLUS Database, Columbus, OH, Accession No. 1992:187881, Reg. No. 46817-91-8, citing “Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline”,psychopharmacology106 (Suppl.).
Cohen et al.,Am. J. Clin. Pathol.105:589 (1996).
Hermans et al., “4-Substituted Piperidines. II. Reaction of 1-Benzyl-4-cyano-4-t-aminopiperidines with Organometallic Compounds”,J. Med. Chem.8(6):851-855 (1965) at p. 852 (“compound 12” in Table I).
Patani and LaVoie, “Bioisosterism: A Rational Approach in Drug Design”,Chem. Rev.96:3147-3176 (1996).
STN International, File CAPLUS, CAPLUS accession No. 1988:630911, Document No. 109:230911, Lehmann, Jochen et al: “Lactones. XVIII. Synthesis of lactone-bridged 1,1-diarylpropanamines”; &Arch. Pharm.(Weinheim, Ger.) (1988), 321(7), 443-445.
Machii et al., “Preparation of 5-cyanopyrimidine derivatives as anti-inflammatory agents”, CAPLUS 139:307788 (2003).
Mattson et al., “Preparation of [(oxopyrrolidinylmethyl)piperidinyl]pyrimidines as nootropics and memory enhancers”, CAPLUS 116:151786 (1992).
Caffrey Moya
Luckhurst Christopher
Mochel Tobias
Perry Matthew
Springthorpe Brian
AstraZeneca AB
Aulakh Charanjit S
Fish & Richardson P.C.
LandOfFree
Chemical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4054400